3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
26
Prostatic Neoplasms
24
Brain Neoplasms
21
Neoplasms
13
Glioma
10
Head and Neck Neoplasms
8
Pancreatic Neoplasms
7
Glioblastoma
6
Lung Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Hepatocellular
5
Astrocytoma
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Lymphoma
4
Central Nervous System Neoplasms
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Liver Neoplasms
3
Disease
3
Retinoblastoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pathologic Complete Response
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Interventions
Radiotherapy
4
Surveys and Questionnaires
3
Specimen Handling
2
Iohexol
2
spartalizumab
1
sodium thiosulfate
1
X-Rays
1
Watchful Waiting
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
FS 069
1
Exercise Test
1
Embolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pelvic Neoplasms
×
Magnetic Resonance Imaging
×
Clear all
NCT06458725
2024-06-14
PILLAR
Jules Bordet Institute
Phase NA
Unknown
30 enrolled